Skip to main content
Clinical Trials/IRCT138812043408N1
IRCT138812043408N1
Completed
Phase 3

Determining the effect of selenium supplement on serum adiponectin and homocystein levels and malnutrition-inflammation complex syndrome (MICS) in hemodialysis patients

Shiraz University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
End stage renal disease , hemodialysis.
Sponsor
Shiraz University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: hemodialysis patients who are on dialysis at least two times per week and in the age range of 17\-85 years.

Exclusion Criteria

  • having infection, hospitalization, taking multivitamins, antibiotics or immunosuppressents, being pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials